Legal Representation
Attorney
Liane L. Churney
USPTO Deadlines
Next Deadline
2138 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-10)
Due Date
June 10, 2031
Grace Period Ends
December 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 10, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Jun 10, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Apr 22, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Apr 22, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 16, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Mar 28, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Mar 27, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 27, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 27, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 28, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jan 28, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jan 28, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jan 27, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 27, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jan 27, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Oct 30, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Oct 30, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Oct 30, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Oct 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 17, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Apr 17, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hemorrhagic diseases and disorders, endocrine diseases and disorders, namely, growth disorders, thyroid disorders, genitourinary diseases and disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, oncological diseases and disorders, hepatological diseases and disorders, and hormonal diseases and disorders
Classification
International Classes
005